Last reviewed · How we verify
NCT00713349
A Randomized, Evaluator Blinded, Controlled Study of the Effect of Xenaderm® Ointment Vehicle Versus White Petrolatum on Healing of Induced Thermal Wounds
Phase 2 trial testing Xenaderm Vehicle in Wounds in 25 participants. Completed in 1 September 2008.
1 August 2008
Quick facts
| Lead sponsor | Healthpoint |
|---|---|
| Phase | Phase 2 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | single group |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 25 |
| Start date | 1 June 2008 |
| Primary completion | 1 August 2008 |
| Estimated completion | 1 September 2008 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Xenaderm Vehicle — full drug profile →
- Placebo comparator
Conditions studied
- Wounds — all drugs for Wounds →
Sponsor
Healthpoint — full company profile →
Who can join
18 and older, any sex, with Wounds. Healthy volunteers can join.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
Complete Wound Closure
Time frame: 21 Days
Each subject acting as their own control
Sponsor's own description
The objective of the study is to compare the healing of wounds induced by cryo-injury when treated with white petrolatum versus an ointment vehicle.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT00713349
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Wounds
Currently open trials in the same condition.
- NCT06921707 — Pilot Trial for WounDx™ Clinical Decision Support Tool · NA · recruiting
- NCT05608317 — A Clinical Investigation to Follow the Progress of Exuding Chronic Venous Leg Ulcers Using a Non-Bordered Foam Dressing · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT00713349 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Healthpoint
- Last refreshed: 9 October 2013
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00713349.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing